Resources for You
Avelox (moxifloxacin hydrochloride)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- April 2009
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.|
|Brand (Generic) Name||
Avelox (moxifloxacin hydrochloride) Tablets
Avelox (moxifloxacin hydrochloride in NaCl injection) I.V.
Label approved 04/27/2009 is not available on Drugs@FDA
“new safety information” with the use of Avelox, particularly the increased risks of tendonitis and tendon rupture.